Guidance on Screening and Symptomatic Breast Imaging!

Breast cancer continues to pose a significant global health challenge, with 2021 marking a diagnostic manoeuvre as it surpassed lung cancer to become the most frequently diagnosed cancer worldwide, particularly impacting women.

Faced with this hindrance, effective breast cancer screening has emerged as a crucial tool in early detection, ultimately leading to improved patient outcomes.

Breast Cancer Screening: Clinical Decision-Making!

The implementation of population-based breast cancer screening programs in developed countries has played a vital role in reducing mortality rates and instances of advanced cancer.

As a result, the need for comprehensive breast cancer screening guidelines has become increasingly apparent, providing clinicians with valuable resources for informed decision-making based on thorough evidence-based reviews and recommendations.

Several developed countries have issued their own breast cancer screening guidelines, each accommodating their respective populations' unique healthcare landscape and demographics. These guidelines aim to standardise and optimise the breast screening process, ensuring that it is both effective and safe for individuals at risk.

NHS breast cancer screening Initiatives!

In the United Kingdom, the National Health Service (NHS) has introduced breast cancer screening with the explicit goal of saving lives.

By detecting breast cancers in their early stages, the screening program seeks to identify tumours that are too small to be detected through physical examination, ultimately contributing to better prognoses for affected individuals.

It's important to note, however, that while screening is effective, it may not prevent the onset of breast cancer entirely.

Breast screening has some risks!

Despite the benefits of breast cancer screening, it's important to acknowledge that the process is not without its risks. Some women undergoing screenings may receive diagnoses and subsequent treatments for breast cancer that may not have given a significant risk or would have remained undetected through routine checks. This highlights the importance of considering the potential downsides of screening and balancing them against the potential benefits.

Routine breast screening is recommended!

For women aged 50 to 70, routine breast screening is offered every three years, serving as a proactive approach to early cancer detection.

Additionally, selected individuals outside of this age range may also be invited to participate in screening programs as part of ongoing studies to assess the effectiveness of screening in different age groups.

It is crucial to emphasise that the risks and benefits of breast cancer screening should be carefully weighed, and individuals are encouraged to engage in informed discussions with healthcare providers to make decisions that align with their personal health needs and preferences.

Repeated exposure to X-rays from mammography does carry a slightly higher risk! 

Breast screening primarily involves mammography, a procedure that captures X-ray images of the breast tissue to identify any abnormalities.

While repeated exposure to X-rays does carry a slightly higher risk of developing breast cancer over time, this risk is minimal. The ultimate goal of early detection is to increase the likelihood of breast-conserving surgeries and improve long-term survival rates for individuals diagnosed with breast cancer.

One of the factors that further complicate the interpretation of breast imaging is the variability in breast density and tissue distribution among women, particularly those with dense breasts. 

Koning 3D Breast Imaging aims to solve this complexity, offering a comprehensive solution that outperforms traditional barriers and empowers healthcare providers and patients with zero breast compression, no pain, and low-dose radiation exposure, with the medical screening tool needed for accurate diagnosis and management of breast cancer conditions.

By leveraging the insights and recommendations provided by breast cancer screening guidelines, clinicians and patients can navigate the complexities of breast cancer management with informed confidence, potentially leading to improved outcomes and quality of life for those affected. Euronoxx Medical presenting a Koning 3D Breast Imaging Medical device for women's breast scanning in collaboration with Koning Corporation.

We made it easy for the UK population to scan breast health more accurately and effectively.